Zelboraf (Vemurafenib)

Zelboraf (Vemurafenib) is an oral prescription medicine used in targeted therapy for certain types of cancer. It belongs to the BRAF inhibitor class and is taken as directed by a healthcare provider. Always consult a doctor for personalized treatment advice.

Zelboraf is primarily used to treat melanoma, a type of skin cancer, when the cancer cells have a specific BRAF V600 mutation. It may also be prescribed for other cancers with this mutation, such as lung cancer. Patients often ask, 'What is Zelboraf used for?' to understand its role in treatment plans. This medication works by blocking signals that cause cancer cells to grow.

Common effects of Zelboraf may include joint pain, fatigue, or skin reactions like rash. Some patients experience nausea or changes in taste. These effects vary and should be discussed with a healthcare provider if they persist or worsen.

Zelboraf should be handled with care, especially by those with known allergies to its ingredients. Pregnant or breastfeeding individuals should avoid this medication unless advised otherwise. Regular medical check-ups are important to monitor progress and manage any side effects during treatment.

Zelboraf may interact with other medications, including certain antidepressants, antifungals, or blood thinners. Strong CYP3A4 inhibitors or inducers can affect its levels in the body. Always inform your doctor about all medications and supplements you are taking to avoid potential interactions.